“…The incidence and economic burden of these disorders is set to increase as average global lifespans rise. Further diseases that impinge on the area of perturbed local cAMP signaling include obesity (Cummings et al, 1996;Czyzyk et al, 2008), asthma (Gerthoffer et al, 2013), and neurodegenerative and behavioral disorders (Bernstein et al, 2013;Millar et al, 2005;Reissner, 2013;Renthal et al, 2009;Richter et al, 2011). There is a growing awareness among structural biologists and pharmacologists that the higherorder topology of signaling protein complexes should be considered when contemplating therapeutic intervention (Blundell et al, 2011).…”